🌎 Our Dr. Priyanka Sinha spoke about nasal brushing & the olfactory system as an early window into brain health during a talk at the Museum of Science. Unlike CSF collection/brain biopsies, nasal brushing is rapid, repeatable, and well-tolerated, enabling accessible longitudinal patient monitoring.

🔬This month, our post-doc fellow Dr. Sutapa Som Chaudhury presented on “Neuronal innate immune pathways that drive cell death and inflammation in ALS” at Target ALS, showcasing the ability of TYK2 and JAK family inhibitors to rescue the cytoplasmic dsRNA and Gasdermine E associated neuronal death.

💬 In March, Dr. Benoît Jobin, a post-doctorate fellow of the Albers lab delivered a presentation on “Reduced Olfactory Identification In Subjective Cognitive Decline: A Meta‐Analysis” at the ADPD 2026 conference in Copenhagen, Denmark. Great job Dr. Jobin!

🎉 Excited to share that our team was awarded NAIRR support with Microsoft Azure credits to power our AI research! Big thanks to the National AI Research Resource Pilot and Microsoft for the compute resources that will help accelerate our work. 🚀
nairrpilot.org/projects/awa...

🧠 Join us Wed, Feb 4 at 12:30pm for a talk organized by the @harvardbrainsci.bsky.social - "The Nose as a Window Into the Brain" at HMS. Dr. Mark Albers and patient James Carney discuss nasal biomarkers & brain health. Lunch provided!

The annual Albers Lab winter get-together last weekend was a great success - wonderful conversations, great company, and a perfect way to celebrate the season.

Laura König, PhD candidate in the Albers Lab, was invited to present her work on TYK2 as a novel drug target in neurodegeneration at the 36th International Symposium on ALS/MND in San Diego (Dec 5–7, 2025). We thank the organizers and research community for the engaging discussions and interest.

This week, Albers Lab members attended the annual Mass General Brigham Neurology Research Retreat and shared exciting lab projects. Congrats to PhD candidate Laura König, whose poster on TYK2 in neurodegenerative disease was awarded Best Poster! 👏🧠

Our CHIL 2025 paper reveals that data quality in the MGB EHR is elevated for patients with an MGB PCP. Through a sensitivity analysis on the use of a PCP variable in a study on the impact of antidiabetic drugs on dementia, we demonstrate the importance of considering PCP status in pragmatic trials.

Our work featured in Advances in Motion

#Alzheimers #MGH #SmellTest #Dementia #MCI #LongCovid advances.massgeneral.org/neuro/journa...

Here is an article with a video published by WCVB about our at-home smell test for detecting Alzheimer's Disease and other memory disorders even up to two decades before onset! Thank you, WCVB, for featuring us! www.wcvb.com/article/usin...